UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy

The journal of trauma and acute care surgery, 2014-12, Vol.77 (6), p.811-817

2014

Volltextzugriff (PDF)

Impaired fibrinolysis in critically ill COVID-19 patients

British journal of anaesthesia : BJA, 2021-03, Vol.126 (3), p.590-598

2021

Volltextzugriff (PDF)

Acidic Region Residues 1680–1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689

Thrombosis and haemostasis, 2021-10, Vol.121 (10), p.1274-1288

2021

Volltextzugriff (PDF)

HSF1 Alleviates Microthrombosis and Multiple Organ Dysfunction in Mice with Sepsis by Upregulating the Transcription of Tissue-Type Plasminogen Activator

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.1066-1078

2021

Volltextzugriff (PDF)

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study

European heart journal, 2019-01, Vol.40 (3), p.295-305

2019

Volltextzugriff (PDF)

Comparison of results obtained using clot-fibrinolysis waveform analysis and global fibrinolysis capacity assay with rotational thromboelastography

Scientific reports, 2024-03, Vol.14 (1), p.7602-7602, Article 7602

2024

Volltextzugriff (PDF)

Regulation of plasminogen activation on cell surfaces and fibrin

Journal of thrombosis and haemostasis, 2018-08, Vol.16 (8), p.1487-1497

2018

Volltextzugriff (PDF)

Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays

The journal of trauma and acute care surgery, 2019-04, Vol.86 (4), p.679-685

2019

Volltextzugriff (PDF)

Molecular mechanisms of fibrinolysis

British journal of haematology, 2005-05, Vol.129 (3), p.307-321

2005

Volltextzugriff (PDF)

Endothelial GATA3 is involved in coagulofibrinolytic homeostasis during endotoxin sepsis

Experimental Animals, 2024, pp.24-0079

2024

Volltextzugriff (PDF)

Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis

Thrombosis and haemostasis, 2024-01, Vol.124 (1), p.40-48

2024

Volltextzugriff (PDF)

Hyperfibrinolysis increases blood–brain barrier permeability by a plasmin- and bradykinin-dependent mechanism

Blood, 2016-11, Vol.128 (20), p.2423-2434

2016

Volltextzugriff (PDF)

Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator

The journal of trauma and acute care surgery, 2017-12, Vol.83 (6), p.1014-1022

2017

Volltextzugriff (PDF)

Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin

Thrombosis and haemostasis, 2021-04, Vol.121 (4), p.464-476

2021

Volltextzugriff (PDF)

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms

Journal of thrombosis and haemostasis, 2024-09

2024

Volltextzugriff (PDF)

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

International journal of molecular sciences, 2021-01, Vol.22 (2), p.883

2021

Volltextzugriff (PDF)

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

Journal of thrombosis and haemostasis, 2020-07, Vol.18 (7), p.1752-1755

2020

Volltextzugriff (PDF)

Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19

Thrombosis and haemostasis, 2021-11, Vol.121 (11), p.1417-1426

2021

Volltextzugriff (PDF)

Application of clot‐fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis

International journal of laboratory hematology, 2020-06, Vol.42 (3), p.292-298

2020

Volltextzugriff (PDF)

Inhaled Tranexamic Acid for Hemoptysis Treatment

Chest, 2018-12, Vol.154 (6), p.1379-1384

2018

Volltextzugriff (PDF)

Classifying types of disseminated intravascular coagulation: clinical and animal models

Journal of intensive care, 2014-03, Vol.2 (1), p.20-20, Article 20

Asakura, Hidesaku

2014

Volltextzugriff (PDF)

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation

Respiratory research, 2020-05, Vol.21 (1), p.130-10, Article 130

2020

Volltextzugriff (PDF)

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.2057-2069

2018

Volltextzugriff (PDF)

Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid

The journal of trauma and acute care surgery, 2018-03, Vol.84 (3), p.426-432

2018

Volltextzugriff (PDF)

A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects

Journal of thrombosis and haemostasis, 2017-05, Vol.15 (5), p.961-971

2017

Volltextzugriff (PDF)

1 – 25 von 31.359

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24.120)
Mit Volltextzugriff
(16.039)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(24.377)
Russisch
(1.893)
Deutsch
(1.463)
Japanisch
(1.005)
Französisch
(732)
Italienisch
(584)
Polnisch
(491)
Spanisch
(359)
Chinesisch
(107)
Tschechisch
(72)
Rumänisch
(56)
Ukrainisch
(56)
Portugiesisch
(44)
Niederländisch
(41)
Ungarisch
(39)
Schwedisch
(33)
Dänisch
(28)
Bulgarisch
(24)
Croatian
(24)
Serbian
(20)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(22.972)
Fibrinolysis
(20.241)
Science & Technology
(18.506)
Life Sciences & Biomedicine
(17.976)
Male
(9.766)
Female
(9.482)
Biological And Medical Sciences
(8.785)
Animals
(7.052)
Cardiovascular System & Cardiology
(6.765)
Hematology
(6.752)
Adult
(6.592)
Middle Aged
(6.477)
Peripheral Vascular Disease
(5.714)
Fibrinolysis - Drug Effects
(5.596)
Medical Sciences
(5.444)
Fundamental And Applied Biological Sciences. Psychology
(4.608)
Aged
(4.303)
Blood Coagulation
(4.099)
Molecular And Cellular Biology
(4.078)
Blood Coagulation. Blood Cells
(4.025)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(27.771)
Journals@Ovid Full Text
(11.682)
Ingenta
(10.475)
EZB Electronic Journals Library
(9.933)
Publisher website
(6.896)
Elsevier ScienceDirect Journals Complete
(5.015)
IngentaConnect Journals
(4.567)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(4.018)
Thieme Connect Journals
(3.426)
Wiley Online Library
(2.797)
Wiley Online Library Full Collection 2018
(2.192)
Springer Journals
(1.863)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.191)
Oxford Journals
(742)
Taylor & Francis Journals
(617)
Taylor & Francis:Master (3349 titles)
(583)
SAGE Publications
(546)
Taylor & Francis
(538)
Oxford Journals 2020 Medicine
(528)
BMJ Journals
(450)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(48)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy

Impaired fibrinolysis in critically ill COVID-19 patients

Acidic Region Residues 1680–1684 in the A3 Domain of Factor VIII Contain a Thrombin-Interactive Site Responsible for Proteolytic Cleavage at Arg1689

HSF1 Alleviates Microthrombosis and Multiple Organ Dysfunction in Mice with Sepsis by Upregulating the Transcription of Tissue-Type Plasminogen Activator

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study

Comparison of results obtained using clot-fibrinolysis waveform analysis and global fibrinolysis capacity assay with rotational thromboelastography

Regulation of plasminogen activation on cell surfaces and fibrin

Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays

Molecular mechanisms of fibrinolysis

Endothelial GATA3 is involved in coagulofibrinolytic homeostasis during endotoxin sepsis

Characterization and Usefulness of Clot-Fibrinolysis Waveform Analysis in Critical Care Patients with Enhanced or Suppressed Fibrinolysis

Hyperfibrinolysis increases blood–brain barrier permeability by a plasmin- and bradykinin-dependent mechanism

Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator

Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19

Application of clot‐fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis

Inhaled Tranexamic Acid for Hemoptysis Treatment

Classifying types of disseminated intravascular coagulation: clinical and animal models

SN50 attenuates alveolar hypercoagulation and fibrinolysis inhibition in acute respiratory distress syndrome mice through inhibiting NF-κB p65 translocation

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin‐activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models

Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid

A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects

Suchergebnisse filtern